CCDC170 and breast carcinoma: We checked the clinico-pathological characteristics of 11 ESR1-CCDC170 fusion-positive and 48 fusion-negative patients among 1095 breast cancer patients in Broad GDAC Firehose (Figure 1, Table 1).